Advisors Preferred’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Advisors Preferred’s Portfolio CALT Stock Details CALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,022	Closed	-$81.5K	–	304
2024 Q3	$81.5K	Buy	+2,022	New	+$79.7K	0.01%	170

Advisors Preferred's CALT Position: Q4 2024 in Review

Advisors Preferred sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q4 2024, closing a stake of 2,022 shares — an estimated $81.5K sold.

Advisors Preferred first reported a position in CALT in Q3 2024 and held it in 1 quarter. The position peaked at $81.5K in Q3 2024. 0 funds tracked by Wall St. Rank hold CALT as of Q4 2024.

Advisors Preferred reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Advisors Preferred sold 2,022 Calliditas Therapeutics AB American Depositary Shares shares in Q4 2024, an estimated $81.5K.
Advisors Preferred first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q3 2024 and held it in 1 quarter.
Advisors Preferred's Calliditas Therapeutics AB American Depositary Shares position peaked at $81.5K in Q3 2024.
0 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q4 2024.

Based on Advisors Preferred's 13F filing for Q4 2024, filed 28 Jan 2025.